Company AVAX Technologies, Inc. Other OTC
Equities
AVXT
US0534953056
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -15.98% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -15.98% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Adele Sommerfeld
CEO | Chief Executive Officer | - | 15-10-18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew W. Dahl
CHM | Chairman | 79 | 99-08-31 |
Adele Sommerfeld
CEO | Chief Executive Officer | - | 15-10-18 |
Bruno Maruzzo
BRD | Director/Board Member | 71 | - |
Serge Morrell
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 142,605,753 | 142,605,753 ( 100.00 %) | 0 | 100.00 % |
Company contact information
AVAX Technologies, Inc.
2000 Hamilton Street Suite 204
19130, Philadelphia
+
Sector
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |